FRX Sensulin LLC is a private investment fund based in New York, New York. According to its most recent Form D, filed Mar 15, 2017, it has sold $40,000 of interests to 6 investors since its first sale in Jun 2016. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include LLC FundRx Capital Management; LLC Assure Fund Management II; Mateo Johnson.
- Total raised
- $40,000Cumulative sales reported on Form D
- Investors
- 6
- First sale
- Jun 30, 2016
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- LLC FundRx Capital Management; LLC Assure Fund Management II; Mateo Johnson
- Latest Form D
- Mar 15, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about FRX Sensulin LLC
What is the minimum investment for FRX Sensulin LLC?
FRX Sensulin LLC's latest Form D, filed Mar 15, 2017, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in FRX Sensulin LLC?
FRX Sensulin LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has FRX Sensulin LLC raised?
FRX Sensulin LLC reports $40,000 sold from 6 investors on its Form D filed Mar 15, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is FRX Sensulin LLC based?
FRX Sensulin LLC is based in New York, New York.
When did FRX Sensulin LLC launch?
FRX Sensulin LLC reports its first sale in Jun 2016.
Size compared with every private investment fund
Raised more than 22% of the 2,847 private investment funds based in New York, and more than 1% of all 10,333 that report sales.